Organon sees opportunities in China’s push for high-quality population development
Organon, a global healthcare company, said China’s efforts to improve population development and advance a more health-centered medical system are creating fresh opportunities for global healthcare companies on the sidelines of the China Development Forum 2026 in Beijing. The company said it sees strong potential in areas such as women’s health, fertility support and chronic…









